The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
To describe clinical features, [18 F]-fluorodeoxyglucose (FDG)-PET metabolism and digital pathology in patients with logopenic progressive aphasia and pathologic diagnosis of diffuse Lewy body disease (LPA-DLBD) and compare to LPA patients with other pathologies, as well as patients with classical features of probable dementia with Lewy bodies (pDLB). Via Annals in Neurology